Literature DB >> 20729714

Metabolic and behavioral effects of chronic olanzapine treatment and cafeteria diet in rats.

Alexandre P Muller1, Ana H Tort, Jussânia Gnoatto, Julia D Moreira, Elsa R Vinadé, Marcos L Perry, Diogo O Souza, Diogo R Lara, Luis V Portela.   

Abstract

Olanzapine and highly palatable diets can alter metabolism and brain function. We investigated the interaction of chronic treatment (4 months) with olanzapine and a cafeteria diet on metabolic parameters, memory tasks (spatial and aversive), the elevated plus maze and locomotor activity induced by d-amphetamine. Male Wistar rats were separated into the following groups: standard diet vehicle, standard diet and olanzapine, cafeteria diet vehicle and cafeteria diet and olanzapine. Olanzapine was administered in the drinking water (approximately 1.5 mg/kg/day), and after 3 days of treatment, the rats exhibited an expected anxiolytic effect and reduced amphetamine-induced hyperlocomotion. After 4 months of treatment, cafeteria diet vehicle and cafeteria diet olanzapine rats exhibited an increased body weight and heavier fat pads compared with the standard diet groups. Olanzapine increased only the epididymal and mesenteric fat pads. The cafeteria diet and olanzapine group showed greater glucose intolerance compared with all other groups. The cafeteria diet altered the effects of chronic olanzapine on the performance in the water maze and inhibitory avoidance tasks. Chronic olanzapine treatment failed to affect amphetamine-induced locomotion and to produce anxiolytic effects in the elevated plus maze task, regardless of the diet. Our results suggest that chronic olanzapine caused an increase in fat pads, which is putatively involved in the etiology of many metabolic diseases. Rats on the cafeteria diet were overweight and exhibited glucose intolerance. We did not observe these effects with olanzapine treatment with the standard diet. Moreover, the chronic treatment regimen caused tolerance to the antipsychotic and anxiolytic effects of olanzapine and seemed to potentiate some of the metabolic effects of the cafeteria diet. The cafeteria diet also modified the effects of chronic treatment with olanzapine on cognitive tasks, which may represent an undesirable effect of poor diets in psychiatric patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729714     DOI: 10.1097/FBP.0b013e32833e7f2a

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  4 in total

1.  [Bioinformatic analysis of differentially expressed proteins in the dorsal raphe nucleus of rats after continuous treatment with olanzapine].

Authors:  P Huang; J Zhu; H Li; Y Wang; Y Tang; Q Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-08-20

2.  Intracerebroventricular metformin decreases body weight but has pro-oxidant effects and decreases survival.

Authors:  Luis Valmor Portela; Jussania Gnoatto; Andressa Wigner Brochier; Clarissa Branco Haas; Adriano Martimbianco de Assis; Afonso Kopczynski de Carvalho; Gisele Hansel; Eduardo Rigon Zimmer; Jean Pierre Oses; Alexandre Pastoris Muller
Journal:  Neurochem Res       Date:  2014-12-10       Impact factor: 3.996

3.  Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance.

Authors:  Heidi N Boyda; Michelle Pham; Joyce Huang; Amanzo A Ho; Ric M Procyshyn; Jessica W Y Yuen; William G Honer; Alasdair M Barr
Journal:  Front Pharmacol       Date:  2022-02-15       Impact factor: 5.810

4.  SELENBP1 expression in the prefrontal cortex of subjects with schizophrenia.

Authors:  M Udawela; T T Money; J Neo; M S Seo; E Scarr; B Dean; I P Everall
Journal:  Transl Psychiatry       Date:  2015-08-04       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.